Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Technology
6.1 Introduction
6.2 HIV/AIDS therapeutics market
6.3 Hepatitis therapeutics
6.3.1 Hepatitis B
6.3.2 Hepatitis C
6.4 Herpes therapeutics
6.5 Influenza antivirals
6.6 Others
Chapter 7 Market Segmentation by the end user
7.1 Introduction
7.2 Hospitals
7.3 Clinics
7.4 Ambulatory surgical centres
7.5 Others
Chapter 8 Market Segmentation by Type
8.1 Introduction
8.2 Branded
8.3 Genetics
8.4 Others
Chapter 9 Market Segmentation by Geography
9.1 North America
9.1.1 Introduction
9.1.1 USA
9.1.2 Canada
9.1.3 Mexico
9.1.4 Others
9.2 Europe
9.2.1 Introduction
9.2.2 UK
9.2.3 France
9.2.4 Germany
9.2.5 Italy
9.2.6 Spain
9.2.7 Others
9.3 Asia-Pacific
9.3.1 Introduction
9.3.2 Japan
9.3.3 China
9.3.4 India
9.3.5 Australia
9.3.6 South Korea
9.3.7 Others
9.4 South America
9.4.1 Introduction
9.4.2 Brazil
9.4.3 Argentina
9.4.4 Others
9.5 The Middle-East and Africa
9.5.1 Introduction
9.5.2 South Africa
9.5.3 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles
11.1 Abbott Healthcare
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2 Johnson and Johnson
11.3 Roche Holding Ag
11.4 Cipla
11.5 Merck & Co
11.6 Gilead
11.7 Schering-Plough
11.8 GlaxoSmithKline
11.9 AstraZeneca
11.10 Bristol-Myers-Squibb
11.11 Schering-Plough
11.12 ImmuneMed
11.13 DR Reddy
Chapter 12 Market Estimates and Forecast
13.1 Market Estimates and Forecast 2018-2024(USD Million)
13.1.1 Market Estimation and Forecast by Technology 2018-2024 (USD Million)
13.1.2 Market Estimates and Forecast by Type 2018-2024 (USD Million)
13.1.3 Market Estimates and Forecast by end user 2018-2024 (USD Million)
13.1.4 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
13.1.5 Market Estimates and forecast by company Profiles 2018-2024(USD million)
Chapter 14 Market Insights
14.1 Insights of Industry Experts
14.2 Analyst Opinion (Market Understanding)
14.3 Investment Opportunities
Chapter 15 Appendix
15.1 List of Tables
15.2 List of Figures
